Trial Profile
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Effect of Coadministration of Multiple Doses of BMS-986177 on Aspirin in Healthy Participants
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jan 2018
Price :
$35
*
At a glance
- Drugs Milvexian (Primary) ; Aspirin
- Indications Thrombosis
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 19 Jan 2018 Status changed from recruiting to completed.
- 17 Nov 2017 New trial record